{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:12:26Z","timestamp":1790892746841,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.det.2024.02.010","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T08:35:01Z","timestamp":1710491701000},"page":"495-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adherence to Psoriasis Therapies"],"prefix":"10.1016","volume":"42","author":[{"given":"Kawaiola C.","family":"Aoki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Q.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.det.2024.02.010_bib1","first-page":"38","article-title":"Improving Management Strategies and Patient Adherence in the Treatment of Psoriasis","volume":"21","author":"Feldman","year":"2018","journal-title":"Journal of Managed Care Medicine"},{"issue":"Suppl 2","key":"10.1016\/j.det.2024.02.010_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jdv.12445","article-title":"Non-adherence and measures to improve adherence in the topical treatment of psoriasis","volume":"28","author":"Zschocke","year":"2014","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.det.2024.02.010_bib3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.12968\/pnur.2011.22.10.549","article-title":"Exploring adherence issues in psoriasis care","volume":"22","author":"Maguire","year":"2011","journal-title":"Pract Nurs"},{"issue":"2","key":"10.1016\/j.det.2024.02.010_bib4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","article-title":"Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures","volume":"84","author":"Elmets","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.010_bib5","first-page":"39","article-title":"Biologic treatments of psoriasis: an update for the clinician","volume":"15","author":"Brownstone","year":"2021","journal-title":"Biologics"},{"key":"10.1016\/j.det.2024.02.010_bib6","doi-asserted-by":"crossref","first-page":"2202786","DOI":"10.1080\/09546634.2023.2202786","article-title":"Drug tolerability versus drug safety","volume":"34","author":"Prajapati","year":"2023","journal-title":"J\u00a0Dermatol Treat"},{"key":"10.1016\/j.det.2024.02.010_bib7","series-title":"Adherence to long-term therapies: Evidence for action","author":"World Health Organization","year":"2003"},{"issue":"Suppl 4","key":"10.1016\/j.det.2024.02.010_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2011.04060.x","article-title":"Maximizing patient adherence for optimal outcomes in psoriasis","volume":"25","author":"Bewley","year":"2011","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2024.02.010_bib9","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.2147\/PPA.S117006","article-title":"Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature","volume":"10","author":"Belinch\u00f3n","year":"2016","journal-title":"Patient Prefer Adherence"},{"issue":"5","key":"10.1016\/j.det.2024.02.010_bib10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A\u00a0new taxonomy for describing and defining adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.det.2024.02.010_bib11","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1080\/09546634.2019.1623371","article-title":"Improving psoriasis patients\u2019 adherence to topical drugs: a systematic review","volume":"31","author":"Svendsen","year":"2020","journal-title":"J\u00a0Dermatol Treat"},{"key":"10.1016\/j.det.2024.02.010_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.det.2024.02.010_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/09546634.2016.1181256","article-title":"Adherence in dermatology","volume":"28","author":"Ahn","year":"2017","journal-title":"J\u00a0Dermatol Treat"},{"issue":"12","key":"10.1016\/j.det.2024.02.010_bib14","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1111\/jdv.15913","article-title":"A\u00a0systematic review of factors influencing treatment adherence in chronic inflammatory skin disease\u2013strategies for optimizing treatment outcome","volume":"33","author":"Eicher","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2024.02.010_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jocd.14610","article-title":"Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study","volume":"21","author":"Oguz Topal","year":"2022","journal-title":"J\u00a0Cosmet Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.02.010_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bjd.12039","article-title":"Adherence to medication in patients with psoriasis: a systematic literature review","volume":"168","author":"Thorneloe","year":"2013","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.02.010_bib17","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jaad.2018.06.053","article-title":"Drug utilization patterns and adherence in patients on systemic medications for the treatment of psoriasis: A retrospective, comparative cohort study","volume":"79","author":"Dommasch","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.02.010_bib18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/archderm.140.4.408","article-title":"Objective assessment of compliance with psoriasis treatment","volume":"140","author":"Zaghloul","year":"2004","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.02.010_bib19","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jaad.2008.08.028","article-title":"Psoriasis: improving adherence to topical therapy","volume":"59","author":"Feldman","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.02.010_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2008.03.045","article-title":"One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic","volume":"59","author":"Storm","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.010_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1468-3083.2012.04525.x","article-title":"Adherence to topical treatment in psoriasis: a systematic literature review","volume":"26","author":"Devaux","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.det.2024.02.010_bib22","doi-asserted-by":"crossref","first-page":"e768","DOI":"10.1111\/jdv.17435","article-title":"A\u00a0study of corticophobia in adult psoriasis patients: a French cross-sectional observational study","volume":"35","author":"Moreau","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2024.02.010_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00128071-200607040-00004","article-title":"Pharmionics in dermatology","volume":"7","author":"Maibach","year":"2006","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.02.010_bib24","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/bjd.15086","article-title":"Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis","volume":"176","author":"Thorneloe","year":"2017","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.02.010_bib25","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/bjd.15085","article-title":"Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring","volume":"176","author":"Alinia","year":"2017","journal-title":"Br J Dermatol"},{"issue":"23","key":"10.1016\/j.det.2024.02.010_bib26","first-page":"01347","article-title":"Holiday holidays: a reduction in topical medication adherence during the winter holidays","volume":"S0190-9622","author":"Kontzias","year":"2023","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.02.010_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s13555-016-0129-2","article-title":"The patient's guide to psoriasis treatment. part 1: UVB phototherapy","volume":"6","author":"Singh","year":"2016","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2024.02.010_bib28","doi-asserted-by":"crossref","first-page":"c1490","DOI":"10.1136\/bmj.c1490","article-title":"Cost effectiveness of home ultraviolet B phototherapy for psoriasis: economic evaluation of a randomised controlled trial (PLUTO study)","volume":"340","author":"Koek","year":"2010","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.det.2024.02.010_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jaad.2008.06.007","article-title":"Adherence to acitretin and home narrowband ultraviolet B phototherapy in patients with psoriasis","volume":"59","author":"Yentzer","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.02.010_bib30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1600-0781.2006.00239.x","article-title":"The utility of a data-logging device for measuring adherence to home phototherapy","volume":"22","author":"Yelverton","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"3","key":"10.1016\/j.det.2024.02.010_bib31","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.5070\/D3253043330","article-title":"Adherence to a novel home phototherapy system with integrated features","volume":"25","author":"Cline","year":"2019","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.det.2024.02.010_bib32","series-title":"StatPearls internet","article-title":"Methotrexate","author":"Hanoodi","year":"2023"},{"issue":"2","key":"10.1016\/j.det.2024.02.010_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/09546634.2019.1698699","article-title":"Real-world treatment patterns and healthcare costs of biologics and apremilast among patients with moderate-to-severe plaque psoriasis by metabolic condition status","volume":"32","author":"Feldman","year":"2021","journal-title":"J\u00a0Dermatol Treat"},{"issue":"6","key":"10.1016\/j.det.2024.02.010_bib34","first-page":"4987","article-title":"Aspects concerning patient adherence to anti-TNF\u03b1 therapy in psoriasis: A decade of clinical experience","volume":"18","author":"Mocanu","year":"2019","journal-title":"Exp Ther Med"},{"issue":"3","key":"10.1016\/j.det.2024.02.010_bib35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jaad.2021.06.878","article-title":"Comparison of two-year treatment adherence, persistence, discontinuation, reinitiation, and switching between psoriasis patients treated with ixekizumab or secukinumab in real-world settings","volume":"86","author":"Blauvelt","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.det.2024.02.010_bib36","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1007\/s12325-022-02155-9","article-title":"Real-world biologic adherence, persistence, and monotherapy comparisons in US patients with psoriasis: results from IBM MarketScan\u00ae databases","volume":"39","author":"Leonardi","year":"2022","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.det.2024.02.010_bib37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/09546634.2011.607425","article-title":"Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities","volume":"24","author":"Chan","year":"2013","journal-title":"J\u00a0Dermatol Treat"},{"issue":"11","key":"10.1016\/j.det.2024.02.010_bib38","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1111\/jdv.16759","article-title":"Treatment adherence in psoriatic patients during COVID-19 pandemic: Real-world data from a tertiary hospital in Greece","volume":"34","author":"Vakirlis","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.det.2024.02.010_bib39","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/00005650-199808000-00004","article-title":"Effectiveness of interventions to improve patient compliance: a meta-analysis","volume":"36","author":"Roter","year":"1998","journal-title":"Med Care"},{"issue":"7","key":"10.1016\/j.det.2024.02.010_bib40","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/ajhp\/60.7.657","article-title":"Meta-analysis of trials of interventions to improve medication adherence","volume":"60","author":"Peterson","year":"2003","journal-title":"Am J Health Syst Pharm"},{"issue":"5","key":"10.1016\/j.det.2024.02.010_bib41","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jaad.2021.05.049","article-title":"Leveraging behavioral economics to promote treatment adherence: A primer for the practicing dermatologist","volume":"87","author":"Woodbury","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.02.010_bib42","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jaad.2020.01.044","article-title":"Placebo tailoring improves patient satisfaction of treatment plans in atopic dermatitis","volume":"83","author":"Bashyam","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.02.010_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09546634.2019.1577346","article-title":"The decoy effect","volume":"30","author":"Whitman","year":"2019","journal-title":"J\u00a0Dermatol Treat"},{"issue":"9","key":"10.1016\/j.det.2024.02.010_bib44","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jamadermatol.2017.1271","article-title":"An anchoring-based intervention to increase patient willingness to use injectable medication in psoriasis","volume":"153","author":"Oussedik","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.02.010_bib45","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s13555-021-00500-4","article-title":"Tolerability of and adherence to topical treatments in atopic dermatitis: a narrative review","volume":"11","author":"Tier","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"8","key":"10.1016\/j.det.2024.02.010_bib46","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1365-2230.2011.04126.x","article-title":"Participation, satisfaction and knowledge level of patients with cutaneous psoriasis or psoriatic arthritis","volume":"36","author":"Renzi","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.02.010_bib47","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/S0190-9622(03)00912-5","article-title":"Electronic monitoring of medication adherence in skin disease: results of a pilot study","volume":"49","author":"Balkrishnan","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.02.010_bib48","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jaad.2004.01.052","article-title":"Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use","volume":"51","author":"Carroll","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.02.010_bib49","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1080\/09546634.2022.2071821","article-title":"Internet-based survey intervention improves adherence to methotrexate among psoriasis patients","volume":"33","author":"Cline","year":"2022","journal-title":"J\u00a0Dermatol Treat"},{"issue":"1","key":"10.1016\/j.det.2024.02.010_bib50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2133.2012.11205.x","article-title":"Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis","volume":"168","author":"Balato","year":"2013","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.02.010_bib51","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/bjd.16667","article-title":"A\u00a0smartphone application supporting patients with psoriasis improves adherence to topical treatment: a randomized controlled trial","volume":"179","author":"Svendsen","year":"2018","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.02.010_bib52","doi-asserted-by":"crossref","first-page":"18182","DOI":"10.5070\/D3195018182","article-title":"Adherence to adalimumab in patients with moderate to severe psoriasis","volume":"19","author":"West","year":"2013","journal-title":"Dermatol Online J"},{"issue":"9","key":"10.1016\/j.det.2024.02.010_bib53","first-page":"504","article-title":"The challenge of managing psoriasis: unmet medical needs and stakeholder perspectives","volume":"9","author":"Feldman","year":"2016","journal-title":"Am Health Drug Benefits"},{"issue":"6","key":"10.1016\/j.det.2024.02.010_bib54","first-page":"1506","article-title":"Adherence and persistence to biological drugs for psoriasis: systematic review with meta-analysis","volume":"11","author":"Piragine","year":"2022","journal-title":"J\u00a0Clin Med"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863524000226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863524000226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T21:39:31Z","timestamp":1716500371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863524000226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0733863524000226"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2024.02.010","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to Psoriasis Therapies","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2024.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}